Ribavirin Treatment for Critically Ill COVID-19 Patients: An Observational Study.

Yonghao XuManshu LiLiang ZhouDongdong LiuWeiqun HeWeibo LiangQingwen SunHuadong SunYimin LiXiaoqing Liu

Published in: Infection and drug resistance (2021)

Ribavirin is well tolerated in critically ill patients with COVID-19 and may benefit COVID-19 patients through increasing the virus clearance.

Keyphrases